Volker Welge

Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease

Volker Welge, Oliver Fiege, Piotr Lewczuk et al. · Journal of Neural Transmission · 2009 · 144 citations · Full text

Neurodegenerative Diseases, Csf Tau, Alzheimer's Disease +12

Blood‐based neurochemical diagnosis of vascular dementia: a pilot study

Mirko Bibl, Hermann Esselmann, Brit Mollenhauer et al. · Journal of Neurochemistry · 2007 · 57 citations

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia

Mirko Bibl, Marion Gallus, Volker Welge et al. · Journal of Neural Transmission · 2012 · 53 citations · Full text

CSF amyloid‐β 1‐38 and 1‐42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction

Mirko Bibl, Piotr Lewczuk, Hermann Esselmann et al. · PROTEOMICS - CLINICAL APPLICATIONS · 2008 · 27 citations

Csf Biomarker Tests, Neurochemical Biomarkers, Biomarker (Medicine) +25

Stability of amyloid‐β peptides in plasma and serum

Mirko Bibl, Volker Welge, Hermann Esselmann et al. · Electrophoresis · 2012 · 22 citations